Julie Tracy, IRC

Senior Vice President, Chief Communications Officer, Wright Medical Group

Julie Tracy is Senior Vice President and Chief Communications Officer for Wright Medical Group N.V., a global orthopaedic medical device company and recognized leader of surgical solutions for the extremities and biologics markets.  As a member of the company’s executive team, she leads the investor relations and corporate communication functions and is responsible for developing and executing investor relations programs to support the valuation of the company’s stock and is Wright’s primary liaison with institutional investors and analysts.

Wright Medical is consistently recognized for its best-in-class investor relations programs.  Ms. Tracy and Wright Medical were ranked #1 in Institutional Investor’s 2017 All-America Executive Team midcap rankings in the Life Science & Diagnostic Tools and Medical Supplies & Devices category.  At the 2014, 2015 and 2016 IR Magazine U.S. Awards, Wright Medical won the Grand Prix award for best overall small cap IR program, and Ms. Tracy was named Best IR officer in the small cap category.  Ms. Tracy was also named the Global Top Small/Mid-Cap Investor Relations Officer in 2014 by IR Magazine.

Prior to Wright Medical, Ms. Tracy served as Senior Vice President and Chief Communications Officer for several leading publicly-traded healthcare companies, including ev3 Inc. (acquired by Covidien) and Kyphon Inc. (acquired by Medtronic).  

Julie currently serves as a member of the NIRI National Board of Directors and is a member of the inaugural class who earned the Investor Relations Charter (IRC) credential in April 2016.  She also is a member of the NIRI Senior Roundtable.

Ms. Tracy graduated magna cum laude from the University of Southern California with a B.S. degree in Business Administration and received her M.B.A. from Pepperdine University's Graziadio School of Business.